Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 382 of 1,261
  1. US 10849975

    Multivalent vaccines for rabies virus and filoviruses

    The United States of America, as Represented by the Secretary, Department of Health and Human Services Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  2. US 10849970

    Antibody evolution immunogens

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  3. US 10849982

    C3-carbon linked glutarimide degronimers for target protein degradation

    C4 THERAPEUTICS, INC. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  4. US 10849965

    H3.3 CTL peptides and uses thereof

    The Regents of the University of California · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  5. US 10851058

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  6. US 10849936

    Compositions and methods for C. difficile treatment

    Regents of the University of Minnesota · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  7. US 10849917

    Antisense-induced exon exclusion in type VII collagen

    Sarepta Therapeutics, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  8. US 10849910

    Use of H3K9me3 modulation for enhancing cognitive function

    The Regents of the University of California · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  9. US 10849896

    Sortilin-binding small molecules for increasing glucose uptake

    United States Government as represented by the Department of Veterans Affairs · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  10. US 10849908

    Corticotropin releasing factor receptor antagonists

    SPRUCE BIOSCIENCES, INC. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  11. US 10849902

    Medicament for treating heart failure

    Takeda Pharmaceutical Company Limited · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  12. US 10849891

    Formulations of pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  13. US 10849883

    Benzopyrazole compounds and analogues thereof

    BioCryst Pharmaceuticals, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  14. US 10849878

    Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon

    OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM” · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  15. US 10849875

    Cancer specific lipid targeted peptidomimetics

    The Board of Regents of the University of Texas System · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  16. US 10849867

    Methods and compositions for treating conditions associated with an abnormal inflammatory response

    First Wave Bio, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  17. US 10850011

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  18. US 10842823

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  19. US 10844353

    Methods for preparing therapeutically active cells using microfluidics

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  20. US 10844129

    Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

    Inhibrx, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  21. US 10844102

    Peptides, compositions, and methods for stimulating subcutaneous adipogenesis

    The Regents of the University of California · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  22. US 10844098

    Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use of the protein

    Institute of Biotechnology, Academy of Military Medical Sciences, China · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  23. US 10844052

    LLS compounds for treatment of cancer

    The Regents of the University of California · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  24. US 10842835

    Oncolytic vaccinia virus mutants and using same for cancer treatment

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.